Both the 2014 ESES consensus and the revised 2015 ATA guideline suggest that timing of surgery should be guided by serum calcitonin levels, whereby a rise of calcitonin above the normal value marks transition from C-cell hyperplasia to micro-MTC. This evidence concerns the gene CALCA and medullary thyroid gland carcinoma.